DOC, an Italian pharmaceutical company specialized in the marketing of generic drugs, expands its strategy by broadening its ...

BioLogic Pharma Solutions aims to be the trusted partner for companies handling complex drug development and commercialization pathways.

It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

Combat Counterfeit Medications: SwissRx Coin introduces a blockchain-based traceability system that tracks and verifies the ...

Today, any pharma marketing strategy has ... have a closer look at the patient journey right at the start.” Here, ‘start’ means years before product launch, when decisions are being made ...

The global pharmaceutical water market size was valued at USD 43.36 billion in 2024 and is forecasted to reach around USD 96.25 billion by 2033 with a CAGR of 9.26% from 2024 to 2033. Water is one of ...

Key Insights Significant control over Journey Medical ... on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment ...

The loss of patent exclusivity and the rise of biosimilars (generic versions of biologics) present a major challenge for the pharmaceutical market, particularly for companies with a strong portfolio ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...

CSL has received approval from the EC for Andembry (garadacimab) to prevent recurrent attacks of HAE in patients aged 12 ...

Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...